Tissue repair / recovery

BPC-157

Body Protection Compound 157

Animal data only — no human trials
Based on expert consensus from publicly available videos plus public FDA/regulatory status — not medical advice. Peptides are prescription territory; consult a physician before using anything here.

The Verdict

The internet's favorite recovery peptide — and the one with the biggest evidence gap. Promising in animals, near-zero human data; Attia tried it and felt nothing. Interesting, not proven.

The Evidence

FDA / Legal Status

Not FDA-approved; moved to FDA 'Category 2' (restricts compounding-pharmacy production)

Human Evidence

Essentially zero human randomized trials — animal models, a small case series, and anecdote

Sport / Doping

Widely banned in sport

Safety Flags

  • Upregulates VEGF — theoretical risk of accelerating an existing tumor; experts advise against continuous/preventative use
  • Gray-market supply risks LPS/endotoxin contamination (fever, inflammation)

Who Covers It

Andrew Huberman
Andrew Huberman
Peter Attia
Peter Attia
Rhonda Patrick
Rhonda Patrick
Mark Hyman
Mark Hyman

Other experts in the panel had no substantive coverage of this peptide — we don't guess their position.

Want the deep dive on BPC-157?

This grade is free. Pro unlocks chat with the full expert dataset — ask about dosing, stacks, sourcing, and the exact citations behind every claim.

Cancel anytime

Go Deeper